Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
48.6M
-
Shares change
-
+533K
-
Total reported value, excl. options
-
$5.19B
-
Value change
-
+$42.4M
-
Put/Call ratio
-
0.63
-
Number of buys
-
119
-
Number of sells
-
-92
-
Price
-
$106.97
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q3 2021
277 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q3 2021.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
of 60.4M outstanding shares and own 80.54% of the company stock.
Largest 10 shareholders include Capital World Investors (4.34M shares), VANGUARD GROUP INC (4.29M shares), BlackRock Inc. (4.02M shares), ARK Investment Management LLC (3.95M shares), FMR LLC (2.21M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.15M shares), Nikko Asset Management Americas, Inc. (2.15M shares), JPMORGAN CHASE & CO (1.81M shares), Invesco Ltd. (1.77M shares), and Allianz Asset Management GmbH (1.73M shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.